Frais De Vente Et D'Administration Changement Date
AstraZeneca USD 4.07B 1.73B 2026-09
Autolus Therapeutics Ltd USD 39.95M 4.16M 2026-03
Hikma Pharmaceutical USD 288M 149M 2025-12
Novartis USD 3.08B 163M 2026-09
Roche Holding CHF 6.37B 908M 2026-06
Silence Therapeutics USD 3.73M 2.06M 2025-12